Mediar Therapeutics needed rapid, cross-functional insights in fibrosis. We convened a virtual advisory board of top experts, facilitated real-time collaboration and fast-tracked the feedback loop.

A global oncology biopharma used Health Expert Connect™ to orchestrate 1:1s, a dinner forum and follow-ups across ASCO and EHA—centralizing schedules, compliance tracking and KOL analytics to deepen relationships at scale.

An inflammatory-disease company expanding into nephrology ran asynchronous boards, surveys and chart audits to learn the market fast, refine messaging and engage specialists every six weeks—accelerating entry with lower spend.

A small pharma prepping first launch scaled stakeholder engagement with a lean team, mixing virtual meetings and ongoing discussion to surface payer hurdles and patient insights early, de-risk and beat rivals to key KOLs.